These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 31498954

  • 1. Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.
    Leung PYM, Tran T, Testro A, Paizis K, Kwong J, Whitlam JB.
    Transpl Infect Dis; 2019 Dec; 21(6):e13168. PubMed ID: 31498954
    [Abstract] [Full Text] [Related]

  • 2. Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.
    Sohrabi M, Behzadian F, Hosseini SM, Lashini H.
    Arch Iran Med; 2016 Oct; 19(10):700-703. PubMed ID: 27743434
    [Abstract] [Full Text] [Related]

  • 3. High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
    Baradhi KM, Aure RL, El-Amm JM.
    Transplant Proc; 2018 Oct; 50(1):142-144. PubMed ID: 29407298
    [Abstract] [Full Text] [Related]

  • 4. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K, Kanda Y, Kako S, Asano-Mori Y, Watanabe T, Motokura T, Chiba S, Shiraki K, Kurokawa M.
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [Abstract] [Full Text] [Related]

  • 5. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A.
    Transplantation; 2011 Jul 27; 92(2):217-23. PubMed ID: 21685829
    [Abstract] [Full Text] [Related]

  • 6. Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy.
    Mendez JC, Sia IG, Tau KR, Espy MJ, Smith TF, Chou S, Paya CV.
    Transplantation; 1999 Mar 15; 67(5):755-7. PubMed ID: 10096535
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A.
    Antivir Ther; 2009 Mar 15; 14(5):697-704. PubMed ID: 19704173
    [Abstract] [Full Text] [Related]

  • 8. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
    Marfori JE, Exner MM, Marousek GI, Chou S, Drew WL.
    J Clin Virol; 2007 Feb 15; 38(2):120-5. PubMed ID: 17157554
    [Abstract] [Full Text] [Related]

  • 9. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
    Green CB, O'Riordan A, Griffiths P, Haque T.
    J Clin Virol; 2016 Jul 15; 80():24-6. PubMed ID: 27131599
    [Abstract] [Full Text] [Related]

  • 10. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.
    Martin M, Goyette N, Ives J, Boivin G.
    J Clin Virol; 2010 Apr 15; 47(4):321-4. PubMed ID: 20138805
    [Abstract] [Full Text] [Related]

  • 11. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E, Ozaki KS, Tomiyama H, Granato CF, Camara NO, Pacheco-Silva A.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2031-7. PubMed ID: 17161359
    [Abstract] [Full Text] [Related]

  • 12. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
    Peixoto M, Mascarenhas L, Cunha A, Dutra M, Miranda E, Silva I, Costa S, Galvão B, Cunha A.
    Antivir Ther; 2012 Dec 20; 17(3):585-8. PubMed ID: 22293247
    [Abstract] [Full Text] [Related]

  • 13. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.
    Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle JP, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S, French CMV Resistance Survey Study Group.
    J Antimicrob Chemother; 2010 Dec 20; 65(12):2628-40. PubMed ID: 20961907
    [Abstract] [Full Text] [Related]

  • 14. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Fischer L, Imrich E, Sampaio KL, Hofmann J, Jahn G, Hamprecht K, Göhring K.
    Antiviral Res; 2016 Jul 20; 131():1-8. PubMed ID: 27058773
    [Abstract] [Full Text] [Related]

  • 15. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
    Mousavi-Jazi M, Hökeberg I, Schloss L, Zweygberg-Wirgart B, Grillner L, Linde A, Brytting M.
    Transpl Infect Dis; 2001 Dec 20; 3(4):195-202. PubMed ID: 11844151
    [Abstract] [Full Text] [Related]

  • 16. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ, Zaas AK, Hanson KE, Palmer SM.
    J Heart Lung Transplant; 2007 Dec 20; 26(12):1286-92. PubMed ID: 18096480
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J, Rotjanapan P, Watcharananan SP.
    Transplant Proc; 2017 Jun 20; 49(5):1048-1052. PubMed ID: 28583524
    [Abstract] [Full Text] [Related]

  • 18. Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
    Allice T, Busca A, Locatelli F, Falda M, Pittaluga F, Ghisetti V.
    J Antimicrob Chemother; 2009 Mar 20; 63(3):600-8. PubMed ID: 19147520
    [Abstract] [Full Text] [Related]

  • 19. Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection.
    Cherrier L, Nasar A, Goodlet KJ, Nailor MD, Tokman S, Chou S.
    Am J Transplant; 2018 Dec 20; 18(12):3060-3064. PubMed ID: 30286286
    [Abstract] [Full Text] [Related]

  • 20. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
    Boivin G, Goyette N, Gilbert C, Covington E.
    J Med Virol; 2005 Nov 20; 77(3):425-9. PubMed ID: 16173018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.